Effects of an amphoteric antiallergic agent, HSR-609, on antigen-induced late phase nasal eosinophilia in Brown Norway rats

Pharmacology

Volumn 61, Issue 4, 2000, Pages 230-237

  Musoh, Keiichi ^a   Nakamura, Nobuaki ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antiallergic agents; Eosinophils; Glucocorticoid; Histamine; Late phase reaction; Nasal allergy

Indexed keywords

3 [4 (8 FLUORO 5,11 DIHYDROBENZ[B]OXEPINO[4,3 B]PYRIDIN 11 YLIDENE)PIPERIDINO]PROPIONIC ACID; AMPHOLYTE; ANTIALLERGIC AGENT; CETIRIZINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PREDNISOLONE;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MALE; NEUTROPHIL; NOSE ALLERGY; PRIORITY JOURNAL; RAT;

EID: 0033646028     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028406     Document Type: Article

References (56)

1. Inflammatory mediators in late antigen-induced rhinitis
2. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy
3. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects: Relationships with early and late inflammatory phenomena
4. 1 receptor blockade on the early and late response to cutaneous allergen challenge
5. The late asthmatic responses
6. Allergen-induced increase in bronchial responsiveness to histamine: Relationship to the late asthmatic response and change in airway caliber
7. Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response
8. Asthma and inflammation
9. The effect of anti-tumor necrosis factor (TNF)-α monoclonal antibody on allergic cutaneous late phase reaction in mice
10. An immunopharmacological study of the biphasic skin reaction in mice
11. The effect of prednisolone on IgE-dependent biphasic cutaneous reaction in BALB/c mice
12. Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs
13. Nasal allergy and leukotrienes: Kinetics of peptide leukotrienes and inflammatory cells in nasal lavage fluid after antigen challenge
14. Infiltration and activation of eosinophils during the late phase response in the subjects with nasal allergy: From a study of nasal lavage fluid
15. Activation of basophilic cells in nasal mucosa after antigen challenge, from the changes in the amount of tryptase in nasal lavage fluids
16. Platelet-activating factor: A potent chemotactic and chemokinetic factor for human eosinophils
17. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products
18. Recombinant human interleukin-5 is a selective eosinophil chemoattractant
19. Highly purified murine interleukin-5 stimulates eosinophil function and prolongs in vitro survival
20. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
21. Recombinant human interleukin-5 is a selective activator of human eosinophil function
22. Reagin synthesis inbred strains of rats
23. Specific and total IgE response to antigenic stimulation in Brown-Norway, Lewis and Sprague-Dawley rats
24. The influence of antigen dose on IgE production in different rat strains
25. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats
26. Effects of prolonged repeated exposure to ovalbumin in sensitized Brown-Norway rats
27. T-cell subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure
28. Airway hyperresponsiveness, elevation of serumspecific IgE and activation of T cell following allergen exposure in sensitized Brown-Norway rats
29. Contribution of intercellular adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitized Brown-Norway rats
30. Airway hyperresponsiveness is associated with inflammation cell infiltration in allergic Brown-Norway rats
31. Effects of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats
32. Amphoteric drugs. 3. Synthesis and antiallergic activity of 3-[(5,11-dihydro[1]benzoxepine[4,3]pyridin-11-ylidene)piperidino]propionic acid derivatives and related compounds
33. Pharmacological studies of HSR-609, a novel amphoteric anti-allergic agent. 1. Effects on various allergic models
34. Pharmacological studies of HSR-609, a novel amphoteric anti-allergic agent. 2. Organ specificity of anti-histamine action
35. 1 receptor
36. Pharmacological characterization of HSR-609, a novel amphoteric antiallergic agent
37. Pharmacological studies on the novel antiallergic agent HSR-609: Its effects on behavior in mice and electroencephalograms in rabbits
38. Central nervous systems effects of novel antiallergic agent HSR-609 and typical antiallergic agents using behavior and electroencephalographic analyses in dogs
39. Disodium cromoglycate (FPL-670) ('Intal'): A specific inhibitor of reaginic antibody-antigen mechanisms
40. Inhibition of histamine secretion from mast cell
41. Inhibition of hypersensitivity reactions by a new drug, n-(3',4'-dimethoxycinnamoyl)anthranilic acid (N-5')
42. The pharmacological properties of a new, orally active antianaphylactic compound: Ketotifen, a benzocycloheptathiophene
43. Antiallergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro
44. A kinetic study of the antihistaminic effect of terfenadine
45. 1-receptor antagonist
46. 2 antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs
47. Nasal cytology in patients with allergic rhinitis: Effects of intranasal fluticasone
48. Correlation between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure
49. Mediator release after nasal airway challenge with antigen
50. Histamine enhanced the TNF-α-induced expression of E-selection and ICAM-1 on vascular endothelial cells
51. Histamine augments VCAM-1 expression on IL-4 and TNF-α-stimulated human umbilical vein endothelial cells
52. 4 and role in allergic leukocyte recruitment
53. 1 antagonist emedastine
54. The role of platelet-activating factor on histamine hypersensitivity in nasal allergy in guinea pig models
55. 2 and histamine in experimental allergic rhinitis of guinea pigs
56. Effects of cysteinyl leukotriene antagonist, ONO-1078 (pranlukast), on total airways resistance after antigen challenge in sensitized guinea pigs